From Crunchbase News: Shares of data automation startup Klaviyo closed up around 9% on their first day of trading on Wednesday, a muted performance for the second big venture-backed IPO of the week. Late Tuesday, the company priced shares at $30 each, a bit above the projected range, raising around $576 million. The offering set an initial valuation[…]
From Crunchbase Startup stock options mean something different in 2023. Many unicorns are staying private for around eight to 10 years while enjoying household name status with public companies like Amazon and Microsoft. Search less. Close more. Some of the highest-valued startups on the The Crunchbase Unicorn Board, including Stripe, Shein and ByteDance, have been around as private companies for longer than a decade. As[…]
By Niloofer Shaikh, HilleVax (HLVX) has priced its upsized initial public offering of 11.765M shares of common stock at $17.00 per share, for gross proceeds of approximately $200M. The offering was upsized from $10.3M shares to 11.765M shares and priced within the estimated range of $16 and $18 per share. The shares are expected to begin trading on[…]
By Renaissance Capital, Magic Empire Global Limited, a Hong Kong-based provider of financial advisory and underwriting services, filed on Friday with the SEC to raise up to $23 million in an initial public offering. The company plans to raise $23 million by offering 5 million shares at a price range of $4 to $5. At[…]
By Renaissance Capital, Bellevue Life Sciences Acquisition, a blank check company backed by Bellevue Capital Management targeting the biotech sector, filed on Friday with the SEC to raise up to $60 million in an initial public offering. The Bellevue, WA-based company plans to raise $60 million by offering 6 million units at $10. Each unit[…]
By Renaissance Capital, In what would be the second largest IPO of the year, eyecare company Bausch + Lomb (BLCO) is scheduled to debut in the week ahead. Some small issuers and SPACs may also price during the week. Planning to dual list on the NYSE and the TSX, Bausch Health spin-off Bausch + Lomb (BLCO) is expected to[…]
By Renaissance Capital, Bausch + Lomb, a leading supplier of contact lenses and eyecare products, announced terms for its IPO on Thursday. The company plans to dual list on the Toronto Stock Exchange. The Vaughan, Canada-based company plans to raise $788 million by offering 35 million shares (100% secondary) at a price range of $21 to[…]
By Khyathi Dalal, ClimateRock (CLRC) priced its 7.5M units IPO at an offer price of $10/unit; each unit consists of one Class A ordinary share, one-half of one redeemable warrant and one right to receive one-tenth of one Class A ordinary share. Each whole warrant holder entitles to purchase one Class A ordinary share, and each ten rights[…]
By Val Kennedy, Novovirus vaccine developer HilleVax (HLVX) has upsized its initial public offering to $175M from $100M. The biotech company said in an amended filing on Monday that it now plans to offer 10.3M shares priced between $16 and $18 per share. If priced at the midpoint, the company would raise approximately $175M. In a filing[…]
By Val Kennedy, BioAffinity Technologies (BIAF), which is developing a test to better detect lung cancer in its earliest stages, has filed for a $19M initial public offering. The Texas-based diagnostics maker didn’t specify the number of shares to be offered and their pricing, but indicated that it hoped to raise up to $19M through[…]